For too many patients, language is an insurmountable barrier to clinical trial participation. We must offer better support to non-English speakers to build trust across cultures.
In this thought-provoking webinar, Univo IRB CEO Julie Blasingim shares practical strategies for improving access, equity, and inclusion in clinical trials. Drawing on decades of experience in research ethics and participant advocacy, she explores how language access can support — not hinder — regulatory compliance and participant understanding.
Watch the webinar to learn:
- The real impact of language barriers on recruitment and retention
- Why accurate translation is only the beginning of informed consent
- How to build trust and understanding across cultural and linguistic differences
- The role of IRBs, interpreters, and community partners in making research more inclusive
